Scientists Discover How Cancer Cells Hijack RNA to Resist Treatment
New research reveals how osteosarcoma cells manipulate RNA stability to maintain aggressive growth and resist chemotherapy.
6520 articles
New research reveals how osteosarcoma cells manipulate RNA stability to maintain aggressive growth and resist chemotherapy.
Study expands treatment options by demonstrating olaparib effectiveness in patients with PALB2 and somatic BRCA mutations.
Major trial reveals blood clot risks vary significantly between different pancreatic cancer treatment approaches.
Oncologists still lack clear guidance on optimal capecitabine dosing, highlighting broader issues in cancer treatment precision.
New circulating tumor DNA test identifies high-risk colon cancer patients with 80% accuracy, potentially revolutionizing treatment decisions.
Camizestrant effectively reduces estrogen receptors and tumor growth at just 75mg daily with minimal side effects in breast cancer patients.
New consensus on genetic testing for cancer drugs creates fresh questions about finding the right dose for each patient.
New research reveals how healthcare delivery systems themselves can function as powerful cancer treatments beyond traditional drugs.
New research reveals how blood-brain barrier differences affect immunotherapy access, potentially improving brain cancer treatment.
New research reveals how brain barrier variations affect cancer treatment delivery, potentially improving outcomes.
Scientists develop CAR T cells that attack tumor-supporting immune cells, showing promise for treating hard-to-target solid cancers.
Engineered immune cells target harmful macrophages in tumors, transforming the cancer environment to boost natural anti-tumor immunity.